Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference

Author's Avatar
Feb 23, 2021
Article's Main Image

Five+Prime+Therapeutics%2C+Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the virtual SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 10:00 a.m. ET / 7:00 a.m. PT.